Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
| Revenue (Most Recent Fiscal Year) | $19.24M |
| Net Income (Most Recent Fiscal Year) | $-8.15M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 5.24 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 10.44 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -41.54% |
| Net Margin (Trailing 12 Months) | -42.34% |
| Return on Equity (Trailing 12 Months) | -84.72% |
| Return on Assets (Trailing 12 Months) | -55.55% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.49 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.16 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 3.91 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.34 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.07 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.28 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.28 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 28.49M |
| Free Float | 27.57M |
| Market Capitalization | $100.85M |
| Average Volume (Last 20 Days) | 0.18M |
| Beta (Past 60 Months) | 1.52 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 44.99% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |